US-based medical college ties up with India's BE to develop COVID-19 vaccine

While countries across globe have ramped up research to find a suitable cure or immunity to vel coronavirus infection, US-based Baylor College of Medicine (BCM) and Indian pharmaceutical company Biological E Limited (BE)  have entered into a licensing agreement to develop safe and effective COVID-19 vaccine. BCM said in a statement that Hyderab-based BE has licensed potential recombinant protein COVID-19 vaccine that was developed at Baylor.

license negotiations between two reportedly took place after initial discussions over techlogy at Baylor’s and how it can contribute to vaccine production amid pandemic. BCM will lever its experiences from past to develop and commercialise COVID-19 vaccine candidate which is currently being produced using a proven yeast-based expression techlogy.

Re - WHO Relaxes Terms For Wealthier Nations To Join Global COVAX Vaccine Facility

Dr Peter Hotez, professor and dean of National School of Tropical Medicine at Baylor said at a webinar organised by Consul General of India in Houston, Aseem Mahajan last week that recent information of India being third-leing nation in terms of COVID-19 cases has sparked concerns of disease is widely spre in urban areas of South Asia. Meanwhile, Mahajan told a national ncy that Indian healthcare sector is expected to witness a drastic growth and it is an opportunity for both nations to build synergies. 

" healthcare sector is predicted to grow steily in India and US. Given complementarities, companies in both countries have a great opportunity to build synergies including to partner toger for global supply chains, joint research and manufacturing," Mahajan said.

Re - Trump Pledges To 'crush' COVID-19 With 'safe, Effective' Vaccine This Year

Hotez & team alrey produce SARS, MERS vaccines

Hotez and his team are alrey manufacturing vaccines for SARs and MERS. vel coronavirus that was discovered in China in December 2019 is kwn to have similarities with SARS or MERS. Until pathogen was named SARS-CoV-19, it was being referred by health officials as SARS-like virus. refore, Hotez and his team were able to quickly move on to creating a COVID-19 vaccine that led to its collaboration with large vaccine producer based in India.

Re - Vlimir Putin Vouches For Russian COVID-19 Vaccine's Safety And Effectiveness

Re - Covishield Trial: Three More Volunteers In Pune ministered Oxford Vaccine Candidate

Inputs/Im: PTI